Evaxion AS (EVAX)
3.28
+0.45
(+15.90%)
USD |
NASDAQ |
Oct 19, 15:33
Evaxion Cash from Operations (Annual) : -6.645M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -6.645M |
| December 31, 2024 | -12.92M |
| December 31, 2023 | -17.72M |
| December 31, 2022 | -25.79M |
| Date | Value |
|---|---|
| December 31, 2021 | -21.90M |
| December 31, 2020 | -12.52M |
| December 31, 2019 | -7.025M |
| December 31, 2018 | -1.976M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Autolus Therapeutics Plc | -284.23M |
| DBV Technologies SA | -121.56M |
| Cellectis SA | -40.14M |
| Akari Therapeutics Plc | -10.59M |
| Bicycle Therapeutics Plc | -250.26M |